Rep. Ro Khanna sold Elanco Animal Health (ELAN)
Rep. Ro Khanna (D-CA-17) · $1K–$15K · traded Jun 5, 2024
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Jun 5, 2024
- Disclosed
- Jul 8, 2024
- Days to disclose
- 33
- Asset type
- Stock
- As filed
- Elanco Animal Health Inc
- Industry
- Drug Manufacturers - Specialty & Generic · Healthcare
Other trades in this filing
All of Khanna's trades →- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jul 2, 2024 · disclosed Jul 8, 2024
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jul 2, 2024 · disclosed Jul 8, 2024
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jun 28, 2024 · disclosed Jul 8, 2024 · Spouse
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jun 27, 2024 · disclosed Jul 8, 2024 · Spouse
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jun 25, 2024 · disclosed Jul 8, 2024 · Spouse
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jun 24, 2024 · disclosed Jul 8, 2024 · Spouse
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jun 24, 2024 · disclosed Jul 8, 2024 · Spouse
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jun 24, 2024 · disclosed Jul 8, 2024 · Spouse
- Jul 8, 2024$15K–$50K
$15K–$50K · Traded Jun 21, 2024 · disclosed Jul 8, 2024
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jun 21, 2024 · disclosed Jul 8, 2024 · Spouse
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jun 21, 2024 · disclosed Jul 8, 2024 · Spouse
- Jul 8, 2024$100K–$250K
$100K–$250K · Traded Jun 21, 2024 · disclosed Jul 8, 2024
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jun 20, 2024 · disclosed Jul 8, 2024 · Spouse
- Jul 8, 2024$50K–$100K
$50K–$100K · Traded Jun 20, 2024 · disclosed Jul 8, 2024
- Jul 8, 2024$50K–$100K
$50K–$100K · Traded Jun 20, 2024 · disclosed Jul 8, 2024
- Jul 8, 2024$50K–$100K
Bought Honeywell International HON
$50K–$100K · Traded Jun 20, 2024 · disclosed Jul 8, 2024
- Jul 8, 2024$50K–$100K
$50K–$100K · Traded Jun 20, 2024 · disclosed Jul 8, 2024
- Jul 8, 2024$50K–$100K
$50K–$100K · Traded Jun 20, 2024 · disclosed Jul 8, 2024
- Jul 8, 2024$50K–$100K
$50K–$100K · Traded Jun 20, 2024 · disclosed Jul 8, 2024
- Jul 8, 2024$1K–$15K
$1K–$15K · Traded Jun 20, 2024 · disclosed Jul 8, 2024 · Spouse
Recent Congress trades in ELAN
- Oct 10, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
Sold Elanco Animal Health ELAN
$1K–$15K · Traded Sep 23, 2025 · disclosed Oct 10, 2025 · Spouse
- Sep 12, 2025$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Elanco Animal Health ELAN
$1K–$15K · Traded Aug 5, 2025 · disclosed Sep 12, 2025 · Dependent
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold (partial) Elanco Animal Health ELAN
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Dec 21, 2022$1K–$15K
Sen. Dan Sullivan (R-AK)
Sold (full) Elanco Animal Health ELAN
$1K–$15K · Traded Nov 30, 2022 · disclosed Dec 21, 2022 · Joint
Company context for ELAN
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
ELAN: third_quarter 2026 lobbying report
Issues related to USICA/COMPETES - provisions related to animal health Issues related to USICA/COMPETES - provisions related to animal health
Public: Oct 20, 2026, 12:26 PM EDTOriginal source ↗ELAN: third_quarter 2026 lobbying report
H.R.2203/S.1906 - Innovative FEED Act of 2025 Farm Bill - Various titles to support animal health-related topics. Several topics regarding tariff and non-tariff policies impacting the US animal health industry. Discussions related to international trade standards (ex. Codex Alimentarius, WOAH). Discussions related to the sanitary and phytosanitary agreement, no specific legislation. Discussions related to supply chain resilience. Issues related to emerging animal diseases and measures to prevent and control such diseases. Issues related to the regulation of animal medicines and biologics as we
Public: Oct 20, 2026, 9:20 AM EDTOriginal source ↗ELAN: second_quarter 2026 lobbying report
Issues related to USICA/COMPETES - provisions related to animal health Issues related to USICA/COMPETES - provisions related to animal health
Public: Jul 20, 2026, 1:57 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.